Gemini administration induced statistically significant, dose dependent changes in key biomarkers of activity-
-Gemini was safe and well tolerated at pharmacologically active doses-
-Phase 1 results enable further development across multiple indications-
https://www.businesswire.com/news/home/20240624937640/en/(Graphic:
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.